Blake Liggio, a partner in the firm’s Real Estate Industry group, focuses on mergers and acquisitions involving public and private entities, including the representation of buyers, sellers and financial advisers. He also advises public companies on a range of matters, including corporate governance, federal securities law compliance and securities offerings. He joined Goodwin in 2010.

Mr. Liggio is also involved in Goodwin’s PropTech Initiative focused on supporting the intersection of Real Estate and Technology through thoughtful collaboration across the two practice areas and advises on relevant market trends impacting the PropTech sector.

Areas of Practice
Domaines D’Expertise





Mergers and acquisitions representations include:

  • Cottonwood Residential in its $1.7 billion restructuring, including its $440 million asset portfolio sale to Ares Capital Management
  • Ablynx NV in its $4.8 billion sale to Sanofi
  • Planet Payment in its $250 million sale to Fintrax Group
  • Monogram Residential Trust in its $4.4 billion sale to a private fund led by Greystar Real Estate Partners
  • NeuStar in its $2.9 billion sale to a private investment group led by Golden Gate Capital and GIC
  • Citrix Systems in the spin-off of its GoTo business and subsequent $1.8 billion sale to LogMeIn through a Reverse Morris Trust transaction
  • The Scion Group LLC in its $1.4 billion acquisition (in joint venture with Canada Pension Plan Investment Board and the Government of Singapore Investment Corporation) of University House Communities Group, Inc.
  • Xoom in its $1 billion sale to PayPal
  • Courier Corporation in its $320 million acquisition by R.R. Donnelley
  • Trulia in its $3.5 billion acquisition by Zillow
  • Onyx Pharmaceuticals in its $10.4 billion sale to Amgen
  • Mid-America Apartment Communities in its $8.6 billion acquisition of Colonial Properties Trust
  • CreXus Investment Corp. in its $1 billion sale to Annaly Capital Management
  • ZOLL Medical in its $2.2 billion sale to Asahi Kasei Corporation
  • in its $80 million sale to Kenexa

Financial advisor M&A representations include:

  • Centerview Partners as financial advisor to Thoratec in its $3.4 billion sale to St. Jude Medical, XenoPort in its $467 million sale to Arbor Pharmaceutical, Idenix in its $3.8 billion sale to Merck, Relypsa in its $1.5 billion sale to Galenica, Qualcomm in its $47 billion acquisition of NXP Semiconductors, Kite Pharma in its $11.9 billion sale to Gilead, and Qualcomm in connection with the unsolicited offer from Broadcom
  • Morgan Stanley as financial advisor to Stemcentrx in its $5.8 billion sale to AbbVie, with up to an additional $4 billion in cash in success-based milestone payments and Lattice Semiconductor in its $1.3 billion sale to Canyon Bridge

Mr. Liggio also provides public company reporting, securities compliance and corporate governance advice to Citrix Systems, Mid-America Apartment Communities, DCT Industrial Trust, Equity One, Unwired Planet and others. Mr. Liggio provides ongoing pro bono advice to The Greater Boston Food Bank on general corporate matters.

Professional Experience

Mr. Liggio served as a law clerk to the Honorable R. Marc Kantrowitz of the Massachusetts Appeals Court, a law clerk for the U.S. Attorney’s Office.


Legal 500 – Real Estate / REITs (2017)

Law360 Rising Star – M&A (2017)

In The News









J.D., 2009
Northeastern University School of Law
B.A., 2003
Colby College

(magna cum laude)


Massachusetts Appeals Court, Honorable R. Marc Kantrowitz



Get In Touch
German Translation
Our clients rely on us for world-class advisory services, counsel on complex transactional work and high-stakes litigation. Specializing in matters involving the financial, life sciences, private equity, real estate, and technology industries, we use a collaborative, cross-disciplinary approach to resolve our clients’ most challenging issues. To find out more, please contact us.

Unsere Kunden verlassen sich auf unsere erstklassige Beratung, vor allem im Hinblick auf komplexe Transaktionen und High-Stakes-Prozesse. Spezialisiert auf Angelegenheiten der Finanz-, Life-Sciences-, Private-Equity-, Immobilien-und Technologie-Branchen, verwenden wir einen kooperativen und interdisziplinären Ansatz, um Fragen unserer Kunden auch in extremen Spezialsituationen einer Lösung zuzuführen. Sie wollen mehr erfahren? Kontaktieren Sie uns gerne.

Nos équipes interviennent aux côtés de nos clients, industriels, fonds d’investissement, startups, institutions financières et dirigeants, dans le cadre de transactions et de contentieux complexes, et apportent des conseils de tout premier plan dans les secteurs financiers, des Sciences de la Vie, du Private Equity, de l’immobilier et des technologies. Nous traitons les dossiers juridiques de manière intègre, ingénieuse, souple et audacieuse pour répondre efficacement aux enjeux propres à chacun de nos clients, quels que soient la taille de l’opération et le secteur d’activité. Pour en savoir plus, contactez-nous.


Search Other Lawyers
Recherche par Pratique